A Prospective, Single-arm Clinical Study of Pabrolizumab in Combination With Cisplatin + 5-FU for the Neoadjuvant Treatment of Unresectable, Advanced Squamous Carcinoma of the Temporal Bone Single-arm Clinical Study

Clinical trial NCT05444673 · UNKNOWN

Trial details

NCT number: NCT05444673
Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Temporal Bone Squamous Cell Carcinoma

Start date: 2022-06-01
Primary completion: 2023-06-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.